Related Experiment Videos
[The distribution of Sn2+ after application as a complex (author's transl)]
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|October 1, 1975
Summary
Animal studies show tin (Sn2+) accumulates in the skeleton after intravenous application. Different tin complexes were tested, informing potential uses in nuclear medicine.
Area of Science:
- Biomedical research
- Radiochemistry
- Pharmacology
Background:
- Tin (Sn2+) is being investigated for potential applications in nuclear medicine.
- Understanding the biodistribution of tin is crucial for its safe and effective use.
Purpose of the Study:
- To investigate the skeletal deposition of Sn2+ after intravenous administration using a radioactive tracer.
- To compare the biodistribution of various Sn2+ complexes.
Main Methods:
- Animal experiments utilizing 113Sn as a radioactive indicator.
- Intravenous (i.v.) administration of Sn2+ in different complex forms (citrate, tartrate, pyrophosphate, phosphate, and Sn2+/HCl).
Main Results:
- 113Sn was observed to deposit in the skeleton following i.v. application.
- Differential skeletal uptake was noted among the tested Sn2+ complexes.
Conclusions:
- The skeletal deposition of Sn2+ is confirmed in animal models.
- The findings have implications for the development and application of Sn2+-based solutions in nuclear medicine for human use.